The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma. (2020)

First Author: Lyons Rimmer J

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers12071744

PubMed Identifier: 32629964

Publication URI: http://europepmc.org/abstract/MED/32629964

Type: Journal Article/Review

Volume: 12

Parent Publication: Cancers

Issue: 7

ISSN: 2072-6694